Addition of suberoylanilide hydroxamic acid (Vorinostat) to azacitidine for patients with higher risk myelodysplastic syndromes and azacitidine failure: a phase II add-on study from the Groupe Francophone des Myelodysplasies

作者:Prebet Thomas; Delaunay Jacques; Wattel Eric; Braun Thorsten; Cony-Makhoul Pascale; Dimicoli Sophie; Wickenhauser Stephan; Lejeune Julie; Chevret Sylvie; Chermat Fatiha; Fenaux Pierre; Vey Norbert
来源:British Journal of Haematology, 2018, 180(5): 735-737.
DOI:10.1111/bjh.14427